share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Gibbs Michael Terrence

SEC announcement ·  Feb 27 16:39
Summary by Moomoo AI
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more